Tomoya Isobe

1.1k total citations
10 papers, 90 citations indexed

About

Tomoya Isobe is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Tomoya Isobe has authored 10 papers receiving a total of 90 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Hematology. Recurrent topics in Tomoya Isobe's work include RNA modifications and cancer (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (2 papers). Tomoya Isobe is often cited by papers focused on RNA modifications and cancer (2 papers), Sarcoma Diagnosis and Treatment (2 papers) and Acute Myeloid Leukemia Research (2 papers). Tomoya Isobe collaborates with scholars based in Japan, United Kingdom and Sweden. Tomoya Isobe's co-authors include Berthold Göttgens, George S. Vassiliou, Chiharu Itagaki, Tomonori Izumi, Kenzaburo Tani, Kazuto Nunomura, Kenichi Nagano, Yasushi Soda, Nicola K. Wilson and Junko Takita and has published in prestigious journals such as Blood, Molecular Cell and PLoS ONE.

In The Last Decade

Tomoya Isobe

10 papers receiving 89 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomoya Isobe Japan	6	55	29	18	15	15	10	90
Ellen Fraint United States	5	44 0.8×	27 0.9×	19 1.1×	18 1.2×	16 1.1×	13	89
Michael I. Barbato United States	4	53 1.0×	11 0.4×	12 0.7×	14 0.9×	9 0.6×	5	85
Fernando Abollo‐Jiménez Spain	7	84 1.5×	28 1.0×	28 1.6×	4 0.3×	19 1.3×	7	136
Sander Lambo Germany	4	70 1.3×	22 0.8×	17 0.9×	31 2.1×	14 0.9×	6	115
Laury Poulain France	4	76 1.4×	20 0.7×	9 0.5×	36 2.4×	55 3.7×	6	132
Heba Ijaz United States	3	71 1.3×	12 0.4×	25 1.4×	14 0.9×	15 1.0×	4	99
Ilana Fox-Fisher Israel	4	64 1.2×	51 1.8×	15 0.8×	14 0.9×	5 0.3×	7	116
Kerry Wall United Kingdom	4	24 0.4×	40 1.4×	12 0.7×	9 0.6×	25 1.7×	5	62
Pradeepta Sekhar Patro India	4	47 0.9×	33 1.1×	10 0.6×	4 0.3×	15 1.0×	9	93
Zsolt Nagy Hungary	5	32 0.6×	13 0.4×	18 1.0×	14 0.9×	14 0.9×	15	85

Countries citing papers authored by Tomoya Isobe

Since Specialization

Citations

This map shows the geographic impact of Tomoya Isobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Isobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Isobe more than expected).

Fields of papers citing papers by Tomoya Isobe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Isobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Isobe. The network helps show where Tomoya Isobe may publish in the future.

Co-authorship network of co-authors of Tomoya Isobe

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Isobe. A scholar is included among the top collaborators of Tomoya Isobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Isobe. Tomoya Isobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Watanabe, Kentaro, Keiji Tasaka, Shota Kato, et al.. (2024). Inhibition of the galactosyltransferase C1GALT1 reduces osteosarcoma cell proliferation by interfering with ERK signaling and cell cycle progression. Cancer Gene Therapy. 31(7). 1049–1059. 4 indexed citations

Tang, Chao, Jingliao Zhang, Yan Gao, et al.. (2024). Single-cell epigenetic and clonal analysis decodes disease progression in pediatric acute myeloid leukemia. Blood. 145(11). 1211–1224. 5 indexed citations

Yankova, Eliza, M. S. Vijayabaskar, Tomoya Isobe, et al.. (2023). Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages. Leukemia. 37(10). 2133–2137. 15 indexed citations

Wang, Meng, Xiaonan Wang, Emily Mitchell, et al.. (2023). Genotoxic aldehyde stress prematurely ages hematopoietic stem cells in a p53-driven manner. Molecular Cell. 83(14). 2417–2433.e7. 21 indexed citations

Ueno, Hiroo, Keiji Tasaka, Tomoya Isobe, et al.. (2023). RNA-seq–based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood Advances. 8(5). 1258–1271. 3 indexed citations

Tanaka, Yosuke, Tsuyoshi Fukushima, Tomoya Isobe, et al.. (2022). 3203 – IDENTIFICATION OF DIFFERENTIATION ROOTS OF HEMATOPOIETIC STEM CELLS BY A PAIRED-DAUGHTER ASSAY COMBINED WITH MULTIPLE BARCODING. Experimental Hematology. 111. S146–S146. 1 indexed citations

Kimura, Shunsuke, Masahiro Sekiguchi, Kentaro Watanabe, et al.. (2021). Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism. PLoS ONE. 16(1). e0245526–e0245526. 11 indexed citations

Tasaka, Keiji, Hiroo Ueno, Kai Yamasaki, et al.. (2021). Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma. Cancer Science. 113(4). 1535–1541. 4 indexed citations

Hoshino, Akihiro, Keiko Nomura, Takeru Hamashima, et al.. (2014). Aggressive transformation of anaplastic large cell lymphoma with increased number of ALK-translocated chromosomes. International Journal of Hematology. 101(2). 198–202. 5 indexed citations

10.

Nagano, Kenichi, Chiharu Itagaki, Tomonori Izumi, et al.. (2005). Rb plays a role in survival of Abl-dependent human tumor cells as a downstream effector of Abl tyrosine kinase. Oncogene. 25(4). 493–502. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact